Inventor · disambiguated record
Victor H. Engelhard
Also filed as: ENGELHARD VICTOR H
14 granted patents·7 pending applications·76 citations·filing 1994–2021
91Inventor score
Top patents by PatentIndex Score
21 records- 0185US10654908B2Isolated T cell receptors and methods of use thereforUNIV VIRGINIA PATENT FOUNDATION·Filed 2015·Granted May 19, 2020·4 cites·20 claims
- 0280US8012484B2Method of treating ischemia reperfusion injury by inhibiting NKT cell activityUniv Virginia Patent Found·Filed 2008·Granted Sep 6, 2011·3 cites·10 claims
- 0376US9561266B2Target peptides for immunotherapy and diagnosticsU VA LICENSING & VENTURES GROUP·Filed 2013·Granted Feb 7, 2017·5 cites·18 claims
- 0476US9345755B2Composition and methods for treating melanomaSLINGLUFF JR CRAIG L·Filed 2013·Granted May 24, 2016·3 cites·12 claims
- 0572US7008922B2H-Y antigenUNIV LEIDEN·Filed 2002·Granted Mar 7, 2006·3 cites·3 claims
- 0671US12042530B2Target peptides for immunotherapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Granted Jul 23, 2024·0 cites·7 claims
- 0771US6558671B1Cysteine-depleted peptides recognized by A3-restricted cytotoxic lymphocytes, and uses thereforUNIV VIRGINIA·Filed 1998·Granted May 6, 2003·25 cites·12 claims
- 0868US6878375B1HA-1 antigenUNIV LEIDEN·Filed 2000·Granted Apr 12, 2005·3 cites·6 claims
- 0967US2022041655A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisAGENUS INC·Filed 2021·Application pending·0 cites
- 1061US11987613B2Isolated T cell receptors and methods of use thereforUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Granted May 21, 2024·0 cites·4 claims
- 1157US7019112B1Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses thereforUNIV VIRGINIA·Filed 1997·Granted Mar 28, 2006·12 cites·5 claims
- 1257US2008206268A1HA-1 epitopes and uses thereofGOULMY ELSA A J M·Filed 2007·Application pending·0 cites
- 1355US7205119B2HA-1 antigenUNIV LEIDEN·Filed 2004·Granted Apr 17, 2007·0 cites·11 claims
- 1451US2004092446A1HA-1 epitopes and uses thereofFiled 2003·Application pending·0 cites
- 1551US2006159690A1H-Y antigenUNIV LEIDEN·Filed 2005·Application pending·0 cites
- 1650US6521598B1H-Y antigenUNIV LEIDEN·Filed 1996·Granted Feb 18, 2003·5 cites·3 claims
- 1750US2018066017A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisAGENUS INC·Filed 2017·Application pending·0 cites
- 1848US2017333541A1Target peptides for immunotherapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2016·Application pending·0 cites
- 1947US2013259883A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisHUNT DONALD F·Filed 2011·Application pending·0 cites
- 2045US5770201AHA-2 antigenic peptideRIJSUNIVERSITEIT TE LEIDEN·Filed 1994·Granted Jun 23, 1998·13 cites·11 claims
- 2136US9279011B2Phosphopeptides as melanoma vaccinesTOPALIAN SUZANNE L·Filed 2010·Granted Mar 8, 2016·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Victor H. Engelhard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →